SOLVNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Solventum Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$85.05−0.76 (-0.89%)
Close on Oct 19, 2026
- Market cap
- $14.74B
- P/E (TTM)
- 10.4
- Dividend yield
- –
Solventum statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | Solventum | Industry median |
|---|---|---|
| Market Cap | $14.48B | $229.23M |
| Enterprise Value | $19.15B | $194.73M |
| PE Ratio | 10.40 | 33.41 |
| PS Ratio | 1.74 | 3.14 |
| PB Ratio | 3.02 | 3.19 |
| P/OCF Ratio | 69.27 | 22.23 |
Enterprise value
| Measure | Solventum | Industry median |
|---|---|---|
| EV / Sales | 2.30 | 2.93 |
| EV / EBITDA | 7.42 | 19.97 |
| EV / EBIT | 9.23 | 25.47 |
Income (trailing twelve months)
| Measure | Solventum | Industry median |
|---|---|---|
| Revenue | $8.31B | $102.39M |
| Gross Profit | $4.55B | $60.36M |
| Operating Income | $2.08B | -$4.31M |
| Pretax Income | $1.70B | -$2.26M |
| Net Income | $1.43B | -$6.57M |
| EBITDA | $2.58B | -$1.98M |
| EPS (Diluted) | $8.18 | -$0.07 |
Margins
| Measure | Solventum | Industry median |
|---|---|---|
| Gross Margin | 54.7% | 55.1% |
| Operating Margin | 25.0% | -6.04% |
| Pretax Margin | 20.4% | -4.11% |
| Profit Margin | 17.3% | -10.5% |
| EBITDA Margin | 31.1% | -2.67% |
| FCF Margin | -1.42% | -0.30% |
Returns
| Measure | Solventum | Industry median |
|---|---|---|
| Return on Equity (ROE) | 34.0% | -19.2% |
| Return on Assets (ROA) | 9.78% | -13.3% |
| Return on Invested Capital (ROIC) | 17.2% | -4.11% |
| Return on Capital Employed (ROCE) | 19.6% | -9.07% |
Growth
| Measure | Solventum | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -0.93% | 8.85% |
| Net Income Growth (YoY) | 277.4% | 10.6% |
| EPS Growth (YoY) | 277.0% | 10.6% |
| FCF Growth (YoY) | -180.3% | 10.6% |
| Revenue Growth (3Y CAGR) | 0.79% | 7.08% |
| EPS Growth (3Y CAGR) | 4.51% | 3.06% |
Balance sheet
| Measure | Solventum | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $403.00M | $37.33M |
| Total Debt | $5.08B | $72.66M |
| Net Cash (Debt) | -$4.68B | $3.92M |
| Net Cash Per Share | -$27.47 | $0.28 |
| Equity (Book Value) | $4.80B | $57.36M |
| Book Value Per Share | $28.20 | $2.81 |
| Tangible Book Value | -$3.23B | $10.71M |
| Working Capital | $78.00M | $54.64M |
Financial position
| Measure | Solventum | Industry median |
|---|---|---|
| Current Ratio | 1.02 | 2.50 |
| Quick Ratio | 0.47 | 1.54 |
| Debt / Equity | 1.06 | 0.38 |
| Debt / EBITDA | 1.97 | 2.31 |
| Net Debt / EBITDA | 1.81 | 1.53 |
Cash flow (trailing twelve months)
| Measure | Solventum | Industry median |
|---|---|---|
| Operating Cash Flow | $209.00M | -$653.46K |
| Capital Expenditures | -$327.00M | -$3.69M |
| Free Cash Flow | -$118.00M | -$835.02K |
| FCF Per Share | -$0.69 | -$0.02 |
Efficiency
| Measure | Solventum | Industry median |
|---|---|---|
| Asset Turnover | 0.57 | 0.59 |
| Inventory Turnover | 3.76 | 2.21 |
| Revenue Per Employee | $831.00K | $322.75K |
| Profits Per Employee | $143.40K | -$52.11K |
| Employee Count | 10,000 | 197 |
Dividends and yields
| Measure | Solventum | Industry median |
|---|---|---|
| Earnings Yield | 9.91% | -6.92% |
| FCF Yield | -0.82% | -0.62% |
Shares
| Measure | Solventum | Industry median |
|---|---|---|
| Shares Outstanding | 170,224,000 | 44,856,700 |
| Shares Change (YoY) | 0.23% | 3.35% |
| Shares Change (QoQ) | -1.97% | 0.27% |
| Float | 118,634,000 | 36,934,400 |
| Shares Held by Insiders | 30.3% | 10.6% |
| Shares Held by Institutions | 75.0% | 63.5% |
Taxes
| Measure | Solventum | Industry median |
|---|---|---|
| Income Tax | $261.00M | $1.52M |
| Effective Tax Rate | 15.4% | 18.6% |
Scores
| Measure | Solventum | Industry median |
|---|---|---|
| Graham Number | $72.04 | $34.37 |
| Graham Upside | -15.3% | -58.3% |
| Altman Z-Score | 2.18 | 1.95 |
| Piotroski F-Score | 5 | 5 |
| Beneish M-Score | -2.05 | -2.64 |
Calculated by StockData from Solventum's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.